Preclinical analyses and phase I evaluation of LY2603618 administered in combination with Pemetrexed and cisplatin in patients with advanced cancer
Calvo, Emiliano, Chen, Victor J., Marshall, Mark, Ohnmacht, Ute, Hynes, Scott M., Kumm, Elizabeth, Diaz, H. Bruce, Barnard, Darlene, Merzoug, Farhana F., Huber, Lysiane, Kays, Lisa, Iversen, Philip, Calles, Antonio, Voss, Beatrice, Lin, Aimee Bence, Dickgreber, Nicolas, Wehler, Thomas, Sebastian, Martin
Published in Investigational new drugs (01.10.2014)
Published in Investigational new drugs (01.10.2014)
Get full text
Journal Article
University of Pennsylvania 7th annual conference on statistical issues in clinical trials: Current issues regarding the use of biomarkers and surrogate endpoints in clinical trials (morning panel discussion)
Daniels, Michael, Frangakis, Constantine, Charu, Vivek, Ghosh, Debashis
Published in Clinical trials (London, England) (01.08.2015)
Published in Clinical trials (London, England) (01.08.2015)
Get full text
Journal Article
Conference Proceeding
A Multicenter Randomized Phase II Trial of Mapatumumab, a TRAIL-R1 Agonist Monoclonal Antibody, In Combination with Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma (MM)
Belch, Andrew, Sharma, Atul, Spencer, Andrew, Tarantolo, Stefano, Bahlis, Nizar J, Doval, Dinesh, Gallant, Gilles, Kumm, Elizabeth, Klein, Jerry, Chanan-Khan, Asher A.
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
Panel discussion 1
Dickersin, Kay, Williams, George, George, Stephen
Published in Clinical trials (London, England) (01.12.2012)
Published in Clinical trials (London, England) (01.12.2012)
Get full text
Journal Article
Results of a Phase 2 Trial of HGS-ETR1 (Agonistic Human Monoclonal Antibody to TRAIL Receptor 1) in Subjects with Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL)
Younes, Anas, Vose, Julie M., Zelenetz, Andrew D., Smith, Mitchell R., Burris, Howard, Ansell, Stephen, Klein, Jerry, Kumm, Elizabeth, Czuczman, Myron
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
Fludarabine and Cyclophosphamide Produces a Higher Complete Response Rate and More Durable Remissions than Fludarabine in Patients with Previously Untreated CLL: Intergroup Trial E2997
Flinn, Ian W., Kumm, Elizabeth, Grever, Michael R., Neuberg, Donna, Dewald, Gordon W., Bennett, John M., Paietta, Elisabeth M., Hussein, Mohamad A., Moore, Dennis F., Tallman, Martin S.
Published in Blood (16.11.2004)
Published in Blood (16.11.2004)
Get full text
Journal Article